News & Press Releasessting
July 11, 2016
MORGAN HILL, California – July 11, 2016: Aragen Bioscience, Inc. (Aragen), leading pre-clinical contract research organization specializing in the discovery and early development of high-value biologics and diagnostic products has appointed Oren Beske, Ph.D. as the President of Aragen Bioscience.
January 26, 2016
MORGAN HILL, California – January 28, 2016: Aragen Bioscience, Inc. (Aragen), leading contract research organization specializing in the study and early development of biologic and diagnostic products, has initiated construction on a new, state of the art research facility.
September 8, 2015
Aragen Bioscience Announces Licensing Agreement for Protein Production Technology from ProteoNic Biotechnology
January 2, 2014
GVK BIO and Aragen Bioscience Sign Definitive Agreement to Acquire Aragen Bioscience, Inc.
May 2, 2013
Aragen Bioscience and Innovent Biologics Announce Collaboration for Biotherapeutic Product Development
September 12, 2013
Bullet Bio Provides Update On Recent Financing And Results From Proof-Of-Concept Study For Lead Product Candidate
August 2, 2012
Aragen Bioscience, Inc. successfully completes antibody humanization project
October 26, 2011
XOMA and Aragen Bioscience Announce Antibody Humanization Services AgreementXOMA and Aragen Bioscience Announce Antibody Humanization Services Agreement
June 1, 2011
Aragen Bioscience Announces Cooperative Research and Development Agreement with the U.S. Army
April 5, 2011
Aragen Bioscience Awarded Three PreClinical Development NIAID Subcontracts